<?xml version="1.0" encoding="UTF-8"?>
<ref id="b11-1040797">
 <label>11.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hillmen</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Robak</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Janssens</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial</article-title>. 
  <source>Lancet</source>. 
  <year>2015</year>;
  <volume>385</volume>(
  <issue>9980</issue>):
  <fpage>1873</fpage>â€“
  <lpage>1883</lpage>.
  <pub-id pub-id-type="pmid">25882396</pub-id>
 </mixed-citation>
</ref>
